Zuo L.;Li J.;Hu J.;
<正>Objectives: Bryostatin-1(Bry-1) has been proven to be effective and safe in clinical trials of a variety of immune-related diseases. However, little is known about its effect on Crohn's disease(CD). We aimed to investigate the impact of Bry-1 on CD-like colitis and determine the mechanism underlying this effect.
mice by protecting the intestinal barrier and limiting immune dysfunction;Bryostatin-1 ameliorated experimental colitis in Il-10;
To explore the background and basis of the node document
Documents that have the similar content to the node document